TRAW stock icon

Traws Pharma
TRAW

$0.45
7%

Market Cap: 11.4M

 

About: Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.

Employees: 17

0
Funds holding %
of 6,702 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

39% more capital invested

Capital invested by funds: $1.24M [Q4 2023] → $1.73M (+$488K) [Q1 2024]

0.22% more ownership

Funds ownership: 7.95% [Q4 2023] → 8.16% (+0.22%) [Q1 2024]

7% less funds holding

Funds holding: 27 [Q4 2023] → 25 (-2) [Q1 2024]

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

Research analyst outlook

We haven’t received any recent analyst ratings for TRAW.

Financial journalist opinion

We haven’t received any recent news articles for TRAW.